A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Clinical trial NCT07222761 · RECRUITING
Trial details
- NCT number
- NCT07222761
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-02
- Primary completion
- 2029-05-21
- Enrollment
- 915
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.